Circulating glucagon-like peptide-1 level in patients with liver cirrhosis.

Masoud Nouri-VaskehNeda KhaliliAmirreza KhalajiPouya BehnamLeila AlizadehSara EbrahimiNeda GilaniMehdi MohammadiSeyed Alisalar MadinehzadehMohammad Zarei

Published in: Archives of physiology and biochemistry (2020)

Larger prospective studies are needed to explore the incretin effect in cirrhosis patients compared with healthy individuals.

Keyphrases

ejection fraction
newly diagnosed
patient reported outcomes